TrademarkDir
PM PRIORITY MEDS
LIVE

Serial Number

98340762

Owner

Priority Meds LLC

Attorney

Gregory B. Perleberg

First Use Date

Dec 31, 2022

Filing Date

Jan 3, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PM PRIORITY MEDS Trademark

Serial Number: 98340762 • Registration: 7750198

PM PRIORITY MEDS is a trademark filed by Priority Meds LLC on January 3, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Priority Meds LLC (2 trademarks)

100 Wilshire Boulevard, Suite 700
Santa Monica, CA 90401

Entity Type: 16

Trademark Details

Filing Date

January 3, 2024

Registration Date

April 8, 2025

First Use Anywhere

December 31, 2022

First Use in Commerce

October 11, 2023

Published for Opposition

February 18, 2025

Goods & Services

Health care services, namely, providing health care and medical services by health care professionals via the Internet or telecommunication networks; Healthcare services, namely, providing telehealth, telemedicine, remote health care, virtual health care services; providing a website featuring health, medical, pharmaceutical and wellness information and advice; Consultancy services relating to health care

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 7, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 7, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 7, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2024 CNRT
EXAMINER'S AMENDMENT ENTERED
Oct 28, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 28, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 28, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 31, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 22, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2024 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 11, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2024 REAP
NEW APPLICATION ENTERED
Jan 3, 2024 NWAP

Related Trademarks

More from this Owner

PM PRIORITY MEDS logo

PM PRIORITY MEDS

PM PRIORITY MEDS logo

PM PRIORITY MEDS

PM PRIORITY MEDS logo

PM PRIORITY MEDS